Han Kun Law Offices has served as the PRC legal counsel to the sole sponsor, China International Capital Corporation Hong Kong Securities Limited, in connection with the initial public offering and listing of Beijing Tong Ren Tang Healthcare Investment Co., Ltd. (北京同仁堂医养投资股份有限公司) (the "Company"; Stock Code: 2667.HK) on the Main Board of the Stock Exchange of Hong Kong Limited, facilitating its successful listing.
The Company is a subsidiary of TRT, which strategically focuses on traditional Chinese medicine (TCM) healthcare services in China, delivering comprehensive TCM healthcare services to individual patients, standardized management services to business clients, and a wide selection of healthcare products and other products. Combining medical "treatment (医)" and "care (养)", the Company delivers modernized and customized TCM healthcare services. Using both TCM medication and non-medication treatments, the Company provides patients with regimen suitable for their diversified needs, all backed by standardized management.